Related Experiment Video

Updated: Jul 19, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

[Diabetics in secondary prevention]

D Tschöpe1

  • 1Herz- und Diabeteszentrum NRW, Georgstrasse 11, 32545, Bad Oeynhausen, Germany.

Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|October 3, 2006
PubMed

Insights

Diabetics face higher risks of cardiac insufficiency and death from acute ischemia. Managing blood sugar is crucial for reducing vascular event risks in diabetic patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Neurology

Context:

  • Diabetes mellitus significantly increases the risk of cardiac insufficiency and mortality, primarily due to acute ischemia.
  • Diabetic patients have a higher incidence of myocardial infarction following ischemic events compared to non-diabetics.
  • Chronic coronary diseases are also more prevalent in individuals with diabetes.

Purpose:

  • To investigate the link between diabetes, cardiac events, and the potential therapeutic role of blood sugar management.
  • To explore the relationship between hyperglycemia severity and brain tissue salvage during acute ischemic events.
  • To emphasize the importance of blood glucose control in mitigating vascular risks.

Summary:

  • Diabetes mellitus is associated with a substantially higher incidence of cardiac insufficiency, with acute ischemia causing 75% of deaths.
  • Hyperglycemia severity inversely correlates with salvageable brain tissue volume during ischemic events.
  • Disturbed glucose tolerance is observed in two-thirds of patients, persisting even post-rehabilitation.

Impact:

  • Highlights hyperglycemia as a potential therapeutic target in acute ischemic events.
  • Underscores the critical need for blood sugar adjustment to reduce risks associated with vascular incidents in diabetics.
  • Emphasizes proactive diabetes management for cardiovascular and cerebrovascular health.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...